BRAF and melanoma: Moreover, we reanalyzed the RNA sequence data of the GEO database, and found that 65% of the BRAF-mutation melanoma patients (11 out of 17) gave rise to an upregulated mRNA level of laminB1 after treatment of BRAFi, PLX4720 (Figure 1F).